CLINICAL_TRIALS
trial_result
· 2009-10-20
Clinical Trial Update: A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects [Phase 2, Phase 3]
Summary
A Phase 2/3 safety and efficacy study of Vitreosolve for Non-Proliferative Diabetic Retinopathy has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vitreoretinal Technologies, Inc. | Conditions: Diabetic Retinopathy | Phase 2, Phase 3 | Status: TERMINATED